Log In
BCIQ
Print this Print this
 

Dolorac Nasal Solution (WL-1017)

Also known as: Doxepin nasal spray

  Manage Alerts
Collapse Summary General Information
Company Winston Pharmaceuticals Inc.
Description0.4% nasal spray formulation of doxepin
Molecular Target Histamine receptor ; Serotonin (5-HT) receptor
Mechanism of ActionHistamine receptor blocker
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationPain
Indication DetailsPrevent chronic migraine
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today